These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20557013)

  • 1. [Assessment of coronary artery stents in computed tomography: state of the art].
    Krupiński M; Miszalski-Jamka T; Klimeczek P; Banyś RP; Irzyk M; Laskowicz B; Pasowicz M
    Przegl Lek; 2010; 67(2):123-6. PubMed ID: 20557013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment factors for evaluating the patency of drug-eluting stents and bare metal stents in coronary arteries by 64-slice computed tomography versus conventional coronary angiography.
    Nakamura K; Funabashi N; Uehara M; Suzuki K; Terao M; Okubo K; Mita Y; Maeda F; Komuro I
    Int J Cardiol; 2008 Nov; 130(3):349-56. PubMed ID: 18180050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation and outcome of patients hospitalized for symptomatic in-stent restenosis treated by percutaneous coronary intervention: comparison between drug-eluting stents and bare-metal stents.
    De Labriolle A; Bonello L; Lemesle G; Steinberg DH; Roy P; Xue Z; Kaneshige K; Suddath WO; Satler LF; Kent KM; Pichard AD; Lindsay J; Waksman R
    Arch Cardiovasc Dis; 2009 Mar; 102(3):209-17. PubMed ID: 19375675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.
    Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A
    Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of drug-eluting stent restenosis.
    Ishikawa K; Aoyama Y; Hirayama H
    J Invasive Cardiol; 2012 Apr; 24(4):178-82. PubMed ID: 22477755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography to noninvasively assess in-stent restenosis.
    de Graaf FR; Schuijf JD; van Velzen JE; Boogers MJ; Kroft LJ; de Roos A; Reiber JH; Sieders A; Spanó F; Jukema JW; Schalij MJ; van der Wall EE; Bax JJ
    Invest Radiol; 2010 Jun; 45(6):331-40. PubMed ID: 20404736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of distal/bifurcation left main restenosis after drug eluting stents implantation: single center experience.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Vassilev D; Fraccaro C; Roncon L; Faggian G
    Cardiovasc Revasc Med; 2014 Mar; 15(2):76-9. PubMed ID: 24560299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
    Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M
    Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-stent restenosis and multislice computed tomography: is the method ready to start?
    Martuscelli E; Razzini C; D'Eliseo A; Di Luozzo M; Mauro B; Romeo F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):377-80. PubMed ID: 17443107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT coronary angiography for the follow-up of coronary stent.
    Cademartiri F; Maffie E; Palumbo A; Martini C; Aldrovandi A; Ardissino D; Brambilla V; Coruzzi P; Mollet NR; Krestin GP; de Feyter PJ
    Acta Biomed; 2010 Sep; 81(2):87-93. PubMed ID: 21305872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.
    Doi H; Maehara A; Mintz GS; Yu A; Wang H; Mandinov L; Popma JJ; Ellis SG; Grube E; Dawkins KD; Weissman NJ; Turco MA; Ormiston JA; Stone GW
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1269-75. PubMed ID: 20129555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results.
    Mirabella F; Francaviglia B; Capodanno D; Di Salvo ME; Galassi AR; Ussia GP; Capranzano P; Tamburino C
    J Invasive Cardiol; 2009 Apr; 21(4):145-50. PubMed ID: 19342750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The iatrogenic pathology of percutaneous interventions in coronary arteries.
    Li X; De Winter RJ; Van Der Wal AC
    Minerva Med; 2012 Dec; 103(6):487-502. PubMed ID: 23229368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between four-slice computed tomography and coronary angiography for the assessment of coronary stents.
    Mazzarotto P; Di Renzi P; Paluello GM; Carunchio A; Ricci R; Molisso A; Ceci V; Indolfi C
    J Cardiovasc Med (Hagerstown); 2006 May; 7(5):328-34. PubMed ID: 16645410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year clinical follow up of coronary drug-eluting stent in patients at high risk for coronary restenosis.
    Azzarelli S; Amico F; Galassi AR; Giacoppo M; Argentino V; Fiscella A
    J Invasive Cardiol; 2008 Feb; 20(2):62-6. PubMed ID: 18252969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Compare drug-eluting stent to bare-metal stent in prognosis on treating diffuse coronary lesions].
    Qiao SB; Hou Q; Xu B; Chen J; Liu HB; Yang YJ; Wu YJ; Yuan JQ; Wu Y; Dai J; You SJ; Ma WH; Zhang P; Gao Z; Dou KF; Qiu H; Mu CW; Chen JL; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):487-91. PubMed ID: 16842660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximal coronary artery intervention: stent thrombosis, restenosis and death.
    Calais F; Lagerqvist B; Leppert J; James SK; Fröbert O
    Int J Cardiol; 2013 Dec; 170(2):227-32. PubMed ID: 24211065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restenosis in the coronary stent is an argument for the surgical myocardial revascularization.
    Goleanu V; Tintoiu I; Iacob M; Pinte F; Gafencu M; Mocanu I; Mustaţă D; Droc I; Dumitraşcu G; Greere V; Neagoe G; Lazar O; Labont B; Teodorescu A; Ravescu M; Trandafir D
    Rom J Intern Med; 2003; 41(3):227-35. PubMed ID: 15526506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.